Financhill
Back

Crinetics Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:
$48.01
Seasonality Move:
-13.46%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight buying pressure.

Crinetics Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 48.33 Sell
20-day SMA: 46.81 Buy
50-day SMA: 44.29 Buy
200-day SMA: 35.31 Buy
8-day EMA: 47.67 Buy
20-day EMA: 46.76 Buy
50-day EMA: 44.17 Buy
200-day EMA: 39.29 Buy

Crinetics Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.25 Buy
Relative Strength Index (14 RSI): 56.36 Buy
Chaikin Money Flow: 869167 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.65 - 48.37) Buy
Bollinger Bands (100): (32.54 - 45.74) Buy

Crinetics Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Crinetics Pharmaceuticals, Inc. Stock

Is Crinetics Pharmaceuticals, Inc. Stock a Buy?

CRNX Technical Analysis vs Fundamental Analysis

Sell
38
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy or a Sell?

Crinetics Pharmaceuticals, Inc. Stock Info

Market Cap:
4.6B
Price in USD:
48.01
Share Volume:
1.7M

Crinetics Pharmaceuticals, Inc. 52-Week Range

52-Week High:
54.78
52-Week Low:
24.10
Sell
38
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Crinetics Pharmaceuticals, Inc. Share Price Forecast

Is Crinetics Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Crinetics Pharmaceuticals, Inc.

Is Crinetics Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.25 per share, and a decrease next year of $0.27 per share.

Technical Analysis of Crinetics Pharmaceuticals, Inc.

Should I short Crinetics Pharmaceuticals, Inc. stock?

* Crinetics Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.